Back
Immuneering Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
46
IMRX
Immuneering
Last Price:
2.10
Seasonality Move:
-29.24%
Buy
60
BMRN
Biomarin Pharmaceutical
Last Price:
64.25
Seasonality Move:
12.47%
Sell
46
Immuneering (IMRX)
is a Sell
Is Immuneering a Buy, Sell or Hold?
- The current Immuneering [IMRX] share price is $2.11. The Score for IMRX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- IMRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $63.45. The Score for BMRN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IMRX Stock Price Chart
What is Immuneering's stock price today?
-
The Immuneering share price today is $2.11
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMRX is experiencing slight selling pressure.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $63.45
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.
IMRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 55.23 | Buy |
| Chaikin Money Flow: | -95640 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.84 - 2.12) | Buy |
| Bollinger Bands (100): | (1.12 - 2.28) | Buy |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.1 | Sell |
| Relative Strength Index (14 RSI): | 33.54 | Sell |
| Chaikin Money Flow: | 933432 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (64.12 - 69.52) | Sell |
| Bollinger Bands (100): | (68.19 - 87.29) | Sell |
IMRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.91 | Buy |
| 20-day SMA: | 1.93 | Buy |
| 50-day SMA: | 2.22 | Sell |
| 200-day SMA: | 2.28 | Sell |
| 8-day EMA: | 1.97 | Buy |
| 20-day EMA: | 1.97 | Buy |
| 50-day EMA: | 1.97 | Buy |
| 200-day EMA: | 2.72 | Sell |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.96 | Sell |
| 20-day SMA: | 65.96 | Sell |
| 50-day SMA: | 68.96 | Sell |
| 200-day SMA: | 81.18 | Sell |
| 8-day EMA: | 63.79 | Sell |
| 20-day EMA: | 65.7 | Sell |
| 50-day EMA: | 69.97 | Sell |
| 200-day EMA: | 79.54 | Sell |
Immuneering Earnings Growth & IMRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.22 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.
Immuneering Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biomarin Pharmaceutical Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||